Regulation of blood-brain barrier permeability

Microcirculation

Volumn 8, Issue 2, 2001, Pages 89-104

  Mayhan, William G ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Bacterial meningitis; Blood brain barrier; Bradykinin; Brain injury; Cytokines; Excitatory amino acids; Histamine; Nitric oxide; Oxygen radicals

Indexed keywords

BACTERIA (MICROORGANISMS);

ARACHIDONIC ACID; BRADYKININ; CYTOKINE; EXCITATORY AMINO ACID; HISTAMINE; NITRIC OXIDE;

ANIMAL; ARTICLE; BACTERIAL INFECTION; BLOOD BRAIN BARRIER; HUMAN; HYPERTENSION; METABOLISM; PERMEABILITY; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACID; BACTERIAL INFECTIONS; BLOOD-BRAIN BARRIER; BRADYKININ; CYTOKINES; EXCITATORY AMINO ACIDS; HISTAMINE; HUMANS; HYPERTENSION; NITRIC OXIDE; PERMEABILITY;

EID: 0035321099     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7300154     Document Type: Review

References (191)

1. Abraham CS, Deli MA, Joo F, Megyeri P, Torpier G. (1996). Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Neurosci Lett 208: 85-88.
2. Adachi N, Itoh Y, Oishi R, Saeki K. (1992). Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion. J Cereb Blood Flow Metab 12:477-483.
3. Alexander JT, Saris SC, Oldfield EH. (1989). The effect of interleukin-2 on the blood-brain barrier in 9L gliosarcoma rat model. J Neurosurg 70:92-96.
4. Anthony DC, Bolton SJ, Fearn S, Perry VH. (1997). Age related effects of interleukin-1B on polymorphonuclear neutrophil dependent increases in blood-brain barrier permeability in rats. Brain 120: 435-444.
5. Armstead WM, Mirro R, Busija DW, Leffler CW. (1988). Postischemic generation of superoxide anion by newborn pig brain. Am J Physiol 255:H401-H403.
6. Armstrong BK, Robinson PJ, Rapoport SI. (1987). Size dependent blood-brain barrier opening demonstrated with sucrose and a 200,000-Da dextran. Exp Neurol 97:686-696.
7. Arneric SP, Honig MA, Milner TA, Greco S, Iadecola C, Reis DJ. (1988). Neuronal and endothelial sites of acetylcholine synthesis and release associated with microvessels in rat cerebral cortex: ultrastructural and neurochemical studies. Brain Res 454:11-30.
8. Auer L. (1978). Origin and localization of evans blue extravasations in acutely-induced hypertension in cats. Eur Neurol 17:211-215.
9. Baethmann A, Maier-Hauff K, Kempski O, Unterberg A, Wahl M, Schurer L. (1988). Mediators of brain edema and secondary brain damage. Crit Care Med 16:972-978.
10. Baranczyk-Kuzma A, Audus KL, Guillot FL, Borchardt RT. (1992). Effects of selected vasoactive substances on adenylate cyclase activity in brain, isolated brain microvessels, and primary cultures of brain microvessel endothelial cells. Neurochem Res 17:209-214.
11. Baries DL, Manganiello VC, Hirata F, Vaughan M, Axelrod J. (1983).Bradykinin stimulates phospholipid methylation, calcium influx, prostaglandin formation and cAMP accumulation in human fibroblasts. Proc Natl Acad Sci USA 80:2514-2518.
12. Barone FC, Feuerstein GZ. (1999). Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819-834.
13. Black KL. (1984). Leukotriene C4 induces vasogenic cerebral edema in rats. Prost Leukotr Med 14: 339-340.
14. Black KL, McGillicuddy JE, Gebarski SS, Hoff JT. (1986). Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans. Ann Neurol 19:592-595.
15. Boje KMK. (1995). Cerebrovascular permeability changes during experimental meningitis in the rat. J Pharmacol Exp Therap 274:1199-1203.
16. Boje KMK. (1995). Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the rat. Eur J Pharmacol 272:297-300.
17. Boje KMK. (1996). Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res 720:75-83.
18. Bolton SJ, Anthony DC, Perry VH. (1998). Loss of tight junction protein occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86:1245-1257.
19. Breder CD, Saper CB. (1996). Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res 713:64-69.
20. Brett FM, Mizisin AP, Powell HC, Campbell IL. (1995). Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropath Exp Neurol 54:766-775.
21. Brian JE, Faraci FM, Heistad DD. (1996). Recent insights into the regulation of the cerebral circulation. Clin Exp Pharmacol Physiol 23:449-457.
22. Brightman MW, Hori M, Rapoport SI, Reese TS, Westergaard E. (1979). Osmotic opening of tight junctions in cerebral endothelium. J Comp Neur 152:317-326.
23. Brightman MW, Klatzo I, Olsson Y, Reese TS. (1970). The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 10: 215-239.
24. Brightman MW, Reese TS. (1969). Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 40:618-677.
25. Butt AM. (1995). Effect of inflammatory agents on electrical resistance across the blood-brain barrier in pial microvessels of anesthetized rats. Brain Res 696:145-150.
26. Butt AM, Jones HC. (1992). Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels. Brain Res 569:100-105.
27. Chan PH, Longar S, Chen S, Yu ACH, Hillered L, Chu L, Imaizumi S, Pereira B, Moore K, Woolworth V, Fishman RA. (1989). The role of arachidonic acid and oxygen radicals metabolities In the pathogenesis of vasogenic brain edema and astrocytic swelling. Ann New York Acad Sci 559:237-247.
28. Chan PH, Longar S, Fishman A. (1985). Oxygen free radical: potential edema mediators in brain injury. Brain Edema 317-323.
29. Chan PH, Schmidley JW, Fishman RA, Longar SM. (1984). Brain injury, edema, and vascular permeability changes induced by oxygen derived free radicals. Neurology 34:315-320.
30. Chi OZ, Chang Q, Wang G, Weiss HR. (1997). Effects of nitric oxide on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats. Anesth Analg 84:370-375.
31. 2 induced oedema in rat paw. Gen Pharmacol 22:801-804.
32. Conklin BR, Burch RM, Steranka CR, Axelrod J. (1988). Distinct bradykinin receptors mediate stimulation of prostaglandin synthesis by endothelial cells and fibroblasts. J Pharmacol Exp Therap 244:646-649.
33. Crone C. (1985). The permeability of brain capillaries to non-electrolytes. Acta Physiol Scand 64: 407-417.
34. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossman T. (1999). IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-a, TGF-B1 and blood-brain barrier function. J Neuroimmunol 101:211-221.
35. de Vries HE, Blom-Roosemalen MCM, van Oosten M, de Boer AG, van Berkel TJC, Breimer DD, Kuiper J. (1996). The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Immunol 64: 37-43.
36. de Vries HE, Kuiper J, de Boer AG, van Berkel TJC, Breimer DD. (1997). The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 42: 143-155.
37. Del Maestro RF, Bjork J, Arfors KE. (1981). Increase in microvascular permeability induced by enzymatically generated free radicals. Microvasc Res 22:239-254.
38. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. (2000). Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95-112.
39. Dembinska-Kiec A, Simmet T, Peskar BA. (1984). Formation of leukotriene C4-like material by rat brain tissue. Eur J Pharmacol 99:57-62.
40. Descamps K, Cecchelli R, Torpier G. (1997). Effects of tumor necrosis factor on receptor-mediated endocystosis and barrier function of bovine brain capillary endothelial cell monolayers. J Neuroimmunol 74:173-184.
41. Dickstein JB, Moldofsky H, Hay JB. (2000). Brain-blood permeability: TNF-α promotes escape of protein tracer from CSF to blood. Am J Physiol 279:R148-R151.
42. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW. (1998). Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytl 27:163-173.
43. Domer FR, Boertje SB, Sampson JB. (1985). Permeability of the blood-brain barrier is not changed by vasoactive doses of arachidonic acid or prostaglandins in rats. Res Comm Chem Path Pharmacol 48: 27-37.
44. Dorovini-Zis K, Bowman PD, Betz AL, Goldstein GW. (1984). Hyperosmotic arabinose solutions open the tight junctions between brain capillary endothelial cells in tissue culture. Brain Res 302:383-386.
45. Dropp JJ. (1972). Mast cells in the central nervous system of several rodents. Anal Rec 174:227-233.
46. Dux E, Joo F. (1982). Effects of histamine on brain capillaries. Exp Brain Res 47:252-258.
47. Edvinsson L, Cervos-Navarro J, Larsson LI, Owman Ch, Ronnberg AL. (1977). Regional distribution of mast cells containing histamine, dopamine or 5-hydroxytryptamine in the mammalian brain. Neurology 27:878-883.
48. Ellis EF, Chao J, Heizer ML. (1989). Brain kininogen following experimental brain injury: evidence for a secondary event. J Neurosurg 71:437-442.
49. Elmquist JK, Breder CD, Sherin JE, Scammell TE, Hickey WF, Dewitt D, Saper CB. (1997). Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meingeal macrophages. J Comp Neur 381:119-129.
50. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K. (1996). Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 27:1734-1738.
51. Epstein LG, Gendelman HE. (1993). Human immunodeficiency virus type-1 infection of the nervous system: pathogenic mechanisms. Ann Neurol 429: 436.
52. Estrada C, Gomez C, Martin C. (1995). Effects of TNK-alpha on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture. J Cereb Blood Flow Metab 15:920-928.
53. Faraci FM. (1992). Regulation of the cerebral circulation by endothelium. Pharmacol Therap 56:1-22.
54. Ferro T, Neumann P, Gertzberg N, Clements R, Johnson A. (2000). Protein kinase C-a mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol 278:L1107-L1117.
55. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. (1978). Free radicals in cerebral ischemia. Stroke 9:445-447.
56. Floyd RA. (1990). Role of oxygen radicals in carcinogenesis and brain ischemia. FASEB J 4:2587-2597.
57. Ford-Hutchinson AW. (1985). Leukotrienes: their formation and role as inflammatory mediators. Federation Proc 44:25-29.
58. Furchgott RF, Vanhoutte PM. (1989). Endothelium-derived relaxing and contracting factors. FASEB J 3:2007-2018.
59. Galea E, Gliekstein SB, Feinstein DL, Golanov EV, Reis DJ. (1998). Stimulation of cerebellar fastigial nucleus inhibits interleukin-1B-induced cerebrovascular inflammation. Am J Physiol 275:H2053-H2063.
60. Goldmann EE. (1909). Die aussere und innere Sekretion des gesunden und kranken organismus im lichte der 'vitalen farbung.' Beitraege Klinischen Chürurgie 64:192-265.
61. Goldmann EE. (1913). Vitalfarbung am zentralnervensystem. Abhandlungen Preussischen Adademie der Wissenschaften Physikalisch Mathematisch klasse I:1-60.
62. Gorlach C, Wahl M. (1996). Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide. Peptides 17:1373-1378.
63. Greenwood J. (1991). Mechanisms of blood-brain barrier breakdown. Neuroradiology 33:95-100.
64. Gross PM, Teasdale GM, Graham DI, Angerson WJ, Harper AM. (1982). Intra-arterial histamine increases blood-brain barrier transport in rats. Am J Physiol 243:H307-H317.
65. Gross PM, Weindl A. (1987). Peering through the windows of the brain. J Cereb Blood Flow Metab 7:663-672.
66. Hansson HA, Johansson BB. (1980). Induction of pinocytosis in cerebral vessels by acute hypertension and by hyperosmolar solutions. J Neurosci Res 5: 183-190.
67. Hansson HA, Johansson BB, Blomstrand C. (1975). Ultrastructural studies on cerebrovascular permeability in acute hypertension. Acta Neuropathol 32: 187-198.
68. 2+ entry through conductive pathway modulates receptor mediated increase in microvessel permeability. Am J Physiol 271:H2377-H2387.
69. Heistad DD, Marcus ML. (1979). Effect of sympathetic stimulation on permeability of the blood-brain barrier to albumin during acute hypertension in cats. Circ Res 45:331-338.
70. Homayoun P, Harik SI. (1991). Bradykinin receptors of cerebral microvessels stimulate phosphoinositide turnover. J Cereb Blood Flow Metab 11: 557-566.
71. Hopkins SJ, Rothwell NJ. (1995). Cytokines and the central nervous system. I: Expression and recognition. TINS 18:83-88.
72. Hua XY, Dahlen SE, Lundberg JM, Hammarstrom S, Hedqvist P. (1985). Leukotrienes C4, D4, and E4 cause widespread and extensive plasma extravasation in the guinea pig. Arch Pharmacol 330:136-141.
73. Hughes SR, Williams TJ, Brain SD. (1990). Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol 191:481-484.
74. Ialenti A, Ianaro A, Moncada S, Di Rosa M. (1992). Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211:177-182.
75. Janigro D, West GA, Nguyen TS, Winn HR. (1994). Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ Res 75:528-538.
76. Joo F. (1993). The role of second messenger molecules in the regulation of permeability in the cerebral endothelial cells. Adv Exp Med Biol 331:155-164.
77. Joo F, Rakonezay Z, Wollemann M. (1975). CAMP mediated regulation of the permeability of brain capillaries. Experientia 31:582-584.
78. Joo F, Tosaki A, Olah Z, Koltai M. (1989). Inhibition by H-7 of the protein kinase C prevents formation of brain edema in Sprague-Dawley CFY rats. Brain Res 490:141-143.
79. Kamitani T, Little MH, Ellis EF. (1985). Effect of leukotrienes, 12-HETE, histamine, bradykinin, and 5-hydroxytryptamine on in vivo rabbit cerebral arteriolar diameter. J Cereb Blood Flow Metab 5:554-559.
80. Kamiya T, Katayama Y, Kashiwagi F, Terashi A. (1993). The role of bradykinin in mediating ischemic brain edema in rats. Stroke 24:571-576.
81. Karnushina IL, Palacios JM, Barbin G, Dux E, Joo F, Schwartz JC. (1980). Studies on a capillary rich fraction isolated from brain: histaminic components and characterization of the histamine receptors linked to adenylate cyclase. J Neurochem 34:1201-1208.
82. Kelsall MA, Lewis P. (1960). Mast cells in the brain. Federation Proc 23:1107-1108.
83. Klabunde RE, Anderson DE. (2000). Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage. Eur J Pharmacol 404:387-394.
84. Kontos HA (1985). Oxygen radicals in cerebral vascular injury. Circ Res 57:508-516.
85. Kontos HA, Wei EP. (1986). Superoxide production in experimental brain injury. J Neurosurg 64:803-807.
86. Kontos HA, Wei EP, Kukreja RC, Ellis EF, Hess ML. (1990). Differences in endothelium-dependent cerebral dilation by bradykinin and acetylcholine. Am J Physiol 258:H1261-H1266.
87. Kontos HA, Wei EP, Povlishock JT, Christman CW. (1984). Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res 55:295-303.
88. Kontos HA, Wei EP, Povlishock JT, Dietrich WD, Magiera CJ. (1980). Cerebral arteriolar damage by arachidonic acid and prostaglandin G2. Science 209:1242-1244.
89. Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC. (1997). Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 17: 280-289.
90. Kovacs J, Kaszaki J, Temesvari P, Czesznak A, Abraham CS, Joo F. (1995). The role of cerebral microvessels in the elimination of histamine released during postasphyxiai reperfusion in newborn piglets. Neurosci Lett 195:25-28.
91. Kumura E, Yoshimine T, Iwatsuki KI, Yamanaka K, Tanaka S, Hayakawa T, Shiga T, Kosaka H. (1996). Generation of nitric oxide and superoxide during reperfusion after focal cerebral ischemia in rats. Am J Physiol 270:C748-C752.
92. Lou J, Donati YRA, Juillard P, Giroud C, Vesin C, Mili N, Gran GE. (1997). Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol 151:1397-1405.
93. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenatter AM, Malik AB. (1990). Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85:1991-1998.
94. MacKenzie ET, Strandgaard S, Graham DI, Jones JV, Harper AM, Farrar JK. (1976). Effects of acutely induced hypertension in cuts on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 39:33-41.
95. Maier-Hauff K, Baethmann AJ, Lange M, Schurer L, Unterberg A. (1984). The kallikrein-kinin system as mediator of vasogenic brain edema. Part 2. Studies on kinin formation in focal and perifocal brain tissue. J Neurosurg 61:97-106.
96. Majno G, Gilmore V, Leventhal M. (1967). On the mechanism of vascular leakage caused by histamine-type mediators. Circ Res 21:833-847.
97. Mathiesen T, Andersson B, Loftenius A, von Holst H. (1993). Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 78:562-567.
98. Mayhan WG. (1992). Role of nitric oxide in modulating permeability of the hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation 16:295-305.
99. 4-induced increases in microvascular transport. Am J Physiol 265:H409-H414.
100. Mayhan WG. (1994). Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol 266:H2369-H2373.
101. Mayhan WG. (1995). Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. Brain Res 686:99-103.
102. 2 receptors in disruption of the blood-brain barrier during acute hypertension. Brain Res 738: 337-341.
103. Mayhan WG. (1996). Role of nitric oxide in histamine induced increases in permeability of the blood-brain barrier. Brain Res 743:70-76.
104. Mayhan WG. (1998). Effect of lipopolysaccharide on the permeability and reactivity of the cerebral microcirculation: role of inducible nitric oxide synthase. Brain Res 792:353-357.
105. Mayhan WG. (1999). VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 276:C1148-C1153.
106. Mayhan WG. (2000). Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 866:101-108.
107. Mayban WG. (2000). Inhibition of nitric oxide synthase does not alter basal permeability of the blood-brain barrier. Brain Res 855:143-149.
108. Mayhan WG, Didion SP. (1995). Activation of protein kinase C does not participate in disruption of the blood-brain barrier to albumin during acute hypertension. Brain Res 696:106-112.
109. Mayhan WG, Didion SP, Glutamate-induced disruption of the blood-brain barrier in rats. Role of nitric oxide. Stroke 27:965-970.
110. Mayhan WG, Faraci FM, Spector R, Heistad DD. (1989). Effect of leukotriene D4 on blood flow to cerebrum and choroid plexus. Am J Physiol 257:H834-H838.
111. Mayhan WG, Heistad DD. (1985). Permeability of blood-brain barrier to various sized molecules. Am J Physiol 248:H712-H718.
112. Mayhan WG, Heistad DD. (1986). Role of veins and cerebral venous pressure in disruption of the blood-brain barrier. Circ Res 59:216-220.
113. Mayhan WG, Sahagun G, Spector R, Heistad DD. Effects of leukotriene C4 on the cerebral microvasculature. Am J Physiol 251:H471-H474.
114. Megyeri P, Abrahám CS, Temesvári P, Kovács J, Vas T, Speer CP. (1992). Recombinant human tumor necrosis factor a constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 148:137-140.
115. Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. (1994). Tumor necrosis factor alpha increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165:208-210.
116. Mohanty S, Dey PK, Sharma HS, Singh S, Chansouria JPN, Olsson Y. (1989). Role of histamine in traumatic brain edema. An experimental study in the rat. J Neurol Sci 90:87-97.
117. Morganti-Kossmann MC, Hans VHJ, Lenzlinger PM, Dubs R, Ludwig E, Trentz O, Kossmann T. (1999). TGF-B is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma 16: 617-628.
118. Moskowitz MA, Kiwak KJ, Hekimian K, Levine L. (1984). Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brain after ischemia and reperfusion. Science 224:886-889.
119. Murray MA, Heistad DD, Mayhan WG. (1991). Role of protein kinase C in bradykinin-induced increases in microvascular permeability. Circ Res 68:1340-1348.
120. Nag S, Robertson DM, Dinsdale HB. (1977). Cerebral cortical changes in acute experimental hypertension. Lab Invest 36:150-161.
121. Nag S, Robertson DM, Dinsdale HB. (1979). Quantitative estimate of pinocytosis in experimental acute hypertension. Acta Neuropathol 46:107-116.
122. Nagashima T, Shijing W, Mizoguchi A, Tamaki N. (1994). A possible role of calcium ion in osmotic opening of blood-brain barrier. J Auton Nerv Sys 49:S145-S149.
123. Nakano S, Matsukado K, Black KL. (1996). Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56:4027-4031.
124. Nava E, Rodriguez F, Moreno C, Llinas MT, Salazar FJ. (2000). Release of nitric oxide after acute hypertension. J Cardiovasc Pharmacol 36:444-450.
125. Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz MA. (1992). Oxygen radicals in cerebral ischemia. Am J Physiol 263:H1356-H1362.
126. Neuwelt EA, Dahlborg SA, Goldman D, Dana B, Ramsey FL. (1989). Significant prolongation of survival of primary CNS lymphoma patients by combination chemotherapy given in association with osmotic blood-brain barrier disruption. Proc Am Assoc Cancer Res 30:264.
127. Northover AM. (1989). The effects of TMB-8 on the shape changes of vascular endothelial cells resulting from exposure to various inflammatory agents. Agents and Actions 26:367-371.
128. O'Neill MJ, Hicks C, Ward M. (1996). Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. Eur J Pharmacol 310: 115-122.
129. Olesen SP. (1987). Leakiness of rat brain microvessels to fluorescent probes following craniotomy. Acta Physiol Scand 130:63-68.
130. Olesen SP. (1987). Regulation of ion permeability in frog brain venules, significance of calcium, cyclic nucleotides and protein kinase C. J Physiol 387:59-68.
131. Olesen SP, Crone C. (1986). Substances that rapidly augment ionic conductance of endothelium in cerebral venules. Acta Physiol Scand 127:233-241.
132. Oliver JA. (1992). Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 151:506-511.
133. Orr EL. (1988). Cryogenic lesions induce a mast cell-dependent increase in cerebral cortical histamine levels in the mouse. Neurochem Pathol 8:43-51.
134. Ozyurt E, Graham DI, Woodruff GN, McCulloch J. (1988). Protective effect of the glutamate antagonist, MK-801, in focal cerebral ischemia in cats. J Cereb Blood Flow Metab 8:138-143.
135. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ. (1997). Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev 21:603-613.
136. Paoletti P, Gaetani P, Grignani G, Paccharini L, Silvani V, Rodriguiz R. (1988). CSE leukotriene C4 following subarachnoid hemorrhage. J Neurosurg 69:488-493.
137. Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW. (1998). Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 44: 592-600.
138. Pober JS, Cotran RS. (1990). Cytokines and endothelial cell biology. Physiol Rev 70:427-451.
139. Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, Merrill MJ. (1999). Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropath Exp Neurol 58:613-627.
140. Quagliarello VJ, Wispelwey B, Long WJ, Scheld WM. (1991). Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J Clin Invest 87:1360-1366.
141. Rapoport SI. (1978). Osmotic opening of the blood-brain barrier. Cerebral Vascular Smooth Muscle and its Control Elsevier-North Holland, Inc.: Ciba Foundation Symposium, pp. 237-255.
142. Rapoport SI. (2000). Osmotic opening of the blood-brain barrier: principles, mechanisms, and therapeutic applications. Cell Mol Neurobiol 20:217-230.
143. Reese TS, Karnovsky MJ. (1967). Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34:207-217.
144. Relton JK, Beckey VE, Hanson WL, Whalley ET, CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke 28: 1430-1436.
145. Revest PA, Jones HC, Abbott NJ. (1994). Transendothelial electrical potential across pial vessels in anaesthetized rats: a study of ion permeability and transport at the blood-brain barrier. Brain Res 652: 76-82.
146. Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG. (1995). Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 703:151-155.
147. Rosenblum WI. (1983). Effects of free radical generation on mouse pial arterioles: probable role of hydroxyl radicals. Am J Physiol 245:H139-H142.
148. Saija A, Princi P, Lanza M, Scalese M, Armnejad E, De Sarro A. (1995).Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sciences 56:775-784.
149. Saris SC, Patronas NJ, Rosenberg SA, Alexaner JT, Frank J, Schwartzentruber DJ, Rubin JT, Barba D, Oldfield EH. (1989). The effect of intravenous interleukin-2 on brain water content. J Neurosurg 71: 169-174.
150. Schaeffer RC Jr, Gong F, Bitrick MS Jr, Smith TL. (1993). Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol Heart Circ Physiol 264:H1798-H1809.
151. Shilling L, Wahl M. (1994). Opening of the blood-brain barrier during cortical superfusion with histamine. Brain Res 653:289-296.
152. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954.
153. Shikimi T, Kema R, Matsumoto M, Yamahata Y, Miyata S. (1973). Studies on kinin-like substances in brain. Biochem Pharmacol 22:567-573.
154. Shohami E, Bass R, Wallach D, Yamin A, Gallily R. (1996). Inhibition of tumor necrosis factor alpha (TNKα) activity in rat brain is associated with cerebroprotection after closed head injury. J Cereb Blood Flow Metab 16:378-384.
155. Shukla A, Dikshit M, Srimal RC. (1995). Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium. Neuroreport 6:1629-1632.
156. Shukla A, Dikshit M, Srimal RC. (1996). Nitric oxide-dependent blood-brain barrier permeability alteration in the rat brain. Experientia 52:136-140.
157. Sirois MG, Edelman ER. (1997). VEGF effect on vascular permeability is mediated by synthesis of platelet activating factor. Am J Physiol 272:H2746-H2756.
158. Temesvari P, Abraham CS, Speer CP, Kovacs J, Megyeri P. (1993). Escherichia coli 0111 B4 lipopolysaccharide given intracisternally induces blood-brain barrier opening during experimental neonatal meningitis in piglets. Pediatr Res 34:182-186.
159. Thompson SE, Cavitt J, Audus KL. (1994). Leucine enkephalin effects on paracellular and transcellular permeation pathways across brain microvessel endothelial cell monolayers J Cardiovasc Pharmacol 24:818-825.
160. Tomimoto H, Akiguchi I, Wakita H, Kinoshita A, Ikemoto A, Nakamura S, Kimura J. (1996). Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol 92:281-287.
161. Unterberg A, Dautermann C, Baethmann A, Muller-Esterl W. (1986). The kallikrein-kinin system as mediator in vasogenic brain edema. J Neurosurg 64: 269-276.
162. Unterberg A, Schmidt W, Wahl M, Ellis EF, Marmarou A, Baethmann A. (1991). Evidence against leukotrienes as mediators of brain edema. J Neurosurg 74:773-780.
163. Unterberg A, Wahl M, Baethmann A. (1984). Effects of bradykinin on permeability and diameter of pial vessels in vivo. J Cereb Blood Flow Metab 4: 574-585.
164. Unterberg A, Wahl M, Baethmann A. (1988). Effects of free radicals on permeability and vasomotor response of cerebral vessels. Acta Neuropathol 76: 238-244.
165. Unterberg A, Wahl M, Hammersen F, Baethmann A. (1987). Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid. Acta Neuropathol 73:209-219.
166. Wahl M, Unterberg A, Baethmann A. (1985). Intravital fluorescence microscopy for the study of blood-brain barrier function. Int J Microcir Clin Exp 4:3-18.
167. Wahl M, Unterberg A, Baethmann A. (1986). The effects of free radicals and leukotrienes on blood-brain barrier function. Int J Microcir Clin Exp 5:93-97.
168. Wahl M, Unterberg A, Baethmann A, Schilling L. (1988). Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab 8:621-634.
169. Wahl M, Whalley ET, Unterberg A, Schilling L, Parsons AA, Baethmann A, Young AR. (1996). Vasomotor and permeability effects of bradykinin in the cerebral microcirculation. Immunopharmacology 33:257-263.
170. Wang W, Merrill MJ, Borchardt RT. (1996). Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol 271:C1973-C1980.
171. Wang X, Barone FC, Aiyar NV, Feuerstein GZ. (1997). Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke 28:155-162.
172. Watanabe M, Rosenblum WI. In vivo studies of pial vascular permeability to sodium fluorescein: absence of alterations by bradykinin, histamine, scrotonin, or arachidonic acid. Stroke 18:1157-1159.
173. Webb AA, Muir GD. (2000). The blood-brain barrier and its role in inflammation. J Vet Intern Med 14:399-411.
174. Wei EP, Christman CW, Kontos HA, Povlishock JT. (1985). Effects of oxygen radicals on cerebral arterioles. Am J Physiol 248:H157-H162.
175. Wei EP, Ellison MD, Kontos HA, Povlishock JT. (1986). O2 radicals in arachidonate induced increased blood-brain barrier permeability to proteins. Am J Physiol 251:H693-H699.
176. Westergaard E. (1977). The blood-brain barrier to horseradish peroxidase under normal and experimental conditions. Acta Neuropathol 39:181-187.
177. Westergaard E, van Deurs B, Brondsted HE. (1977). Increased vesicular transfer of horseradish peroxidase across cerebral endothelium, evoked by acute hypertension. Acta Neuropathol 37:141-152.
178. Westergren I, Johansson BB. (1992). NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema. Brain Res 573:324-326.
179. Westergren I, Johansson BB. (1993). Blockade of AMPA receptors reduces brain edema following opening of the blood-brain barrier. J Cereb Blood Flow Metab 13:603-608.
180. Westergren I, Nordborg C, Johansson BB. (1993). Glutamate enhances brain damage and albumin content in cerebrospinal fluid after intracarotid protamine sulfate. Acta Neuropathol 85:285-290.
181. Westergren I, Nystrom B, Hamberger A, Nordborg C, Johansson BB. (1994). Concentrations of amino acids in extracellular fluid after opening of the blood-brain barrier by intracarotid infusion of protamine sulfate. J Neurochem 62:159-165.
182. Woodroofe MN. (1995). Cytokine production in the central nervous system. Neurology 45:S6-S10.
183. Yamada Y, Furumichi T, Furui H, Yokoi T, Ito T, Yamanchi K, Yokota M, Hayashi H, Saito H. (1990). Roles of calcium, cyclic nucleotides, and protein kinase C in regulation of endothelial permeability. Arteriosclerosis 10:410-420.
184. Yang ST, Mayhan WG, Faraci FM, Heistad DD. (1991). Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension 17:612-618.
185. Yokota M, Tani E, Maeda Y. (1989). Biosynthesis of leukotrienes in canine cerebral vasospasm. Stroke 20:527-533.
186. Yuan Y, Granger HJ, Zawieja DC, Chilian WM. (1992). Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am J Physiol Heart Circ Physiol 263:H641-H646.
187. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. (1993). Histamine increases venular permeability via a phospholipase C-NO synthaseguanylate cyclase cascade. Am J Physiol Heart Circ Physiol 264:H1734-H1739.
188. Zhang Z, Chopp M, Goussev A, Powers C. (1998). Cerebral vessels express interleukin-1B after focal cerebral ischemia. Brain Res 784:210-217.
189. Zhao L, Zhang MM, Ng K. (1998). Effects of vascular permeability factor on the permeability of cultured endothelial cells from brain capillaries. J Cardiovasc Pharmacol 32:1-4.
190. Ziylan YZ, Robinson PJ, Rapoport SI. (1983). Differential blood-brain barrier permeabilities to sucrose and inulin after osmotic opening in the rat. Exp Neurol 79:845-857.
191. Zlokovic BV, Apuzzo MLJ. (1997). Cellular and molecular neurosurgery: pathways from concept to reality - Part II: Vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery 40:805-813.